Abstract 224
| OUTCOMES | Nebivolol (beta blocker) | Placebo | Hazard Ratio and 95% CI | p value |
|---|---|---|---|---|
| 1. Death/CV hospitalisation | ||||
| Age <75.2/EF ⩽35% (n = 684) | 27.5% | 35.7% | 0.73 (0.56–0.96) | 0.023 |
| Age ⩾75.2/EF >35% (n = 373) | 30.6% | 37.4% | 0.75 (0.53–1.06) | 0.103 |
| 2. All cause mortality | ||||
| Age <75.2/EF ⩽35% (n = 684) | 13.7% | 21.6% | 0.62 (0.42–0.89) | 0.011 |
| Age ⩾75.2/EF >35% (n = 373) | 16.9% | 16.8% | 0.96 (0.59–1.58) | 0.881 |